ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PRFX vs SILO // ALTMAN Z-SCORE & DEBT/EQUITY

PRF Technologies Ltd. (NASDAQ) VS. Silo Pharma Inc. (NASDAQ) • 15-METRIC TALLY: PRFX 2 — SILO 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRFX VS. SILO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PRFX SILO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 38.60% -68.60 SILO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) — 0.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 36.6 34.1 +2.46 PRFX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.6M $2.4M $246.0K PRFX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PRFX REV SILO REV PRFX GROSS % SILO GROSS % PRFX FCF SILO FCF
FY 2025 $17.0K $72.1K -50.0% 38.6% -$4.0M -$4.7M
FY 2024 $0 $72.1K — 91.9% -$12.6M -$3.8M
FY 2023 $0 $72.1K — — -$6.7M -$3.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRFX // BETA —
SILO // BETA —